Plus: GLP-1 drugs like Ozempic have potential to treat cancer, COVID-19, heart disease, and many other diseases.
Katie Jennings is a Senior Writer at Forbes covering the business of healthcare technology. Her reporting focuses on the latest developments in the healthtech industry, including emerging startups, medical innovations, and the impact of artificial intelligence and other cutting-edge technologies on the healthcare landscape. Prior to Forbes, Jennings has written for publications such as POLITICO, covering policy and regulatory issues in the healthcare sector.